Synergy Mechanism
The CagriSema combination — the most powerful weight loss stack in clinical trials.
GLP-1 (Semaglutide) (glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.) and Cagrilintide (long-acting amylin analog that activates amylin receptors in the hypothalamus to reduce food intake and slow gastric emptying.) work through complementary pathways, producing a synergistic effect greater than either compound alone.
Combined Dosing Protocol
| Compound | Dose | Frequency | WADA |
|---|---|---|---|
| GLP-1 (Semaglutide) | 0.25mg - 2.4mg | Weekly | |
| Cagrilintide | 0.3mg - 2.4mg | Weekly |
Get This Protocol
Hatter Labs provides physician-supervised GLP-1 (Semaglutide) + Cagrilintide stack protocols with GMP-certified compounds.
Get ProtocolStart Your Performance Protocol for GLP-1 (Semaglutide) + Cagrilintide Stack
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised